COMMUNIQUÉS West-GlobeNewswire

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
02/07/2026
SOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter [...]
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
SAN FRANCISCO, July 02, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
02/07/2026
IRVINE, California – July 2, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leader in urology-focused precision diagnostics, today announced that the Company received a [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/07/2026
VANCOUVER, British Columbia and BOSTON, MA, July 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development [...]
Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases
02/07/2026
CHICAGO, July 02, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
CBDrmd.com Launches CBD Gummies and CBD Oil Transparency Initiative
02/07/2026
New educational resource helps adults better understand CBD gummies, CBD oil, product labels, lab reports, ingredient disclosures, THC information, refund policies, and responsible CBD product research. NEW YORK,USA, [...]
GENFIT annonce l’accès à la couverture et le futur remboursement par Medicare aux États-Unis de NASHnext®, une technologie visant à identifier les patients atteints de MASH « à risque »
02/07/2026
Couverture et futur remboursement sécurisés pour NASHnext®, le test diagnostique sanguin non invasif développé par Labcorp, basé sur la technologie propriétaire NIS4® de GENFIT Un ciblage sur les patients les plus à [...]
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines
02/07/2026
NORTH PALM BEACH, Fla., July 02, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled platform dedicated to generating returns across high-conviction operating [...]
Declaration voting rights - June 30,2026
02/07/2026
VALNEVA Declaration of shares and voting rights Status as of June 30, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint- [...]
Profusa Announces 1-for-25 Reverse Stock Split
02/07/2026
BERKELEY, California, July 02, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the [...]
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext®, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
02/07/2026
Coverage and future reimbursement ( effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered by GENFIT’s proprietary NIS4® technology Focuses on patients at highest [...]
Déclaration droits de vote - 30 juin 2026
02/07/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 30 juin 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social [...]
Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
02/07/2026
- Acoramidis initiation was associated with rapid kidney-protective activity as exhibited in a hemodynamically mediated, reversible eGFR dip and a placebo-corrected 15.5% reduction in UACR by Day 28 (P<0.05), with no [...]
Polyrizon Announces Successful Results for NASARIX™ Biocompatibility Program, Supporting Advancement Towards First in Human Clinical Trial
02/07/2026
Raanana, Israel, July 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
02/07/2026
Revenue Increased Sequentially Approximately 170% from Q1 to Q2 (QoQ) as Customer Adoption Accelerates Across Key Travel Markets FORT MILL, S.C., July 02, 2026 (GLOBE NEWSWIRE) -- Flyte, a subsidiary of Catheter [...]
Cannara obtient les droits exclusifs au Canada sur la technologie d’infusion Ampersand™ Live Rosin de Blue River
02/07/2026
Ce partenariat associe le leadership de Cannara dans le domaine du cannabis haut de gamme sans solvant à la technologie d’infusion exclusive de Blue River afin de proposer une nouvelle génération de produits à base de [...]
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
02/07/2026
REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
02/07/2026
New Taipei City, Taiwan, July 02, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]

Pages